A Deadline is coming up on October 27, 2014 in the lawsuit for investors in Lannett Company, Inc. (NYSE:LCI) and NYSE:LCI stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 09/30/2014 -- The Shareholders Foundation announces that a deadline is coming up on October 27, 2014 in the lawsuit filed for investors of Lannett Company, Inc. (NYSE:LCI) over alleged violations of Federal Securities Laws.
Investors who purchased shares of Lannett Company, Inc. (NYSE:LCI) have certain options and there are strict and short deadlines running. Deadline: October 27, 2014. NYSE:LCI stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
According to the complaint filed in the District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Lannett Company, Inc. (NYSE:LCI) common shares between September 10, 2013 and July 16, 2014, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that Defendants made allegedly false and/or misleading statements and/or failed to disclose that Lannett Company, Inc. was fixing, maintaining, and controlling prices of digoxin in violation of Connecticut antitrust laws, that Lannett Company, Inc. was allocating and dividing customers and territories with competitors relating to the sale of digoxin in violation of Connecticut antitrust laws, that Lannett Company, Inc.’s anticompetitive practices subjected Lannett to heightened regulatory scrutiny, including possible investigation by the Connecticut Office of the Attorney General ("CTAG"), and that as a result of the foregoing, Lannett Company, Inc.'s public statements were allegedly materially false and misleading at all relevant times.
On July 16, 2014, Lannett Company, Inc. announced that, "it has received interrogatories and subpoena from the State of Connecticut Office of the Attorney General concerning its investigation into pricing of digoxin. According to the subpoena, the Connecticut Attorney General is investigating whether anyone engaged in any activities that resulted in (a) fixing, maintaining or controlling prices of digoxin or (b) allocating and dividing customers or territories relating to the sale of digoxin in violation of Connecticut antitrust law." Shares of Lannett Company, Inc. declined from over $51 per share in early July 2014 to as low as $33.51 per share during July 31, 2014.
Those who purchased shares of Lannett Company, Inc. (NYSE:LCI) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego